INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA

Country

Luxembourg

Type

Beneficiary

Grants received

15

Funding record

• 15 grants on record
• €10,083,285.63 awarded in total
• 2017–2025 span of the record

Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.

Programmes

• Horizon Europe Framework Programme 5 grants · €4,309,321.25

10 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.

Frequent partners

Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.

• JANSSEN PHARMACEUTICA NV 6 shared projects · 2019–2025 · Belgium
• CHARITE - UNIVERSITAETSMEDIZIN BERLIN 5 shared projects · 2019–2025 · Germany
• ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM 4 shared projects · 2017–2021 · Netherlands
• MEDIZINISCHE UNIVERSITAET WIEN 4 shared projects · 2019–2023 · Austria
• NOVARTIS PHARMA AG 4 shared projects · 2019–2025 · Switzerland
• ABBVIE INC 3 shared projects · 2019–2025 · United States
• ASTRAZENECA AB 3 shared projects · 2019–2025 · Sweden
• BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL 3 shared projects · 2019–2021 · Germany

Calls from this organisation

No published calls from this organisation.

Grants received

• EUropean Cancer Information Portal €24,412.50 · awarded 1 May 2025 · from European Commission
• Research in Europe and Diversity Inclusion €2,337,525 · awarded 1 January 2025 · from European Commission
• Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications €432,500 · awarded 1 September 2024 · from European Commission
• A CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNT €632,383.75 · awarded 1 December 2023 · from European Commission
• Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance €882,500 · awarded 1 April 2023 · from European Commission
• Optimal treatment for patients with solid tumours in Europe through Artificial intelligence €787,500 · awarded 1 October 2021 · from European Commission
• Cyber-Physical Intensive Care Medical System for Covid-19 €168,888.13 · awarded 1 January 2021 · from European Commission
• Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy €312,500 · awarded 1 January 2021 · from European Commission
• Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies €400,501.25 · awarded 1 January 2020 · from European Commission
• Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies €334,560 · awarded 1 December 2019 · from European Commission
• EU Patient- cEntric clinicAl tRial pLatform €184,970 · awarded 1 November 2019 · from European Commission
• Biomarkers in Atopic Dermatitis and Psoriasis €460,360 · awarded 1 April 2019 · from European Commission
• Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease €624,125 · awarded 1 February 2019 · from European Commission
• Citizen-centred EU-EHR exchange for personalised health €2,250,000 · awarded 1 January 2019 · from European Commission
• Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics €250,560 · awarded 1 September 2017 · from European Commission